Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | BOLD | CELU | ||
| Company | Catabasis Pharma | Boundless Bio Inc | Celularity Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 1.5400 | 1.1300 | ||
| High | 9.21 | 1.5500 | 1.2147 | ||
| Low | 8.46 | 1.4600 | 1.0833 | ||
| Latest | 8.54 | 1.5000 | 1.1100 | ||
| Change | -0.64 | -0.0200 | -0.0100 | ||
| % Change | -6.97% | -1.32% | -0.89% | ||
| Volume | 98,800 | 123,700 | 30,200 | ||
| 20-Day Average Volume | 395,311 | 477,055 | 28,955 | ||
| Previous Close | 9.18 | 1.5200 | 1.1200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 1.3298 | 1.2700 | ||
| 20-Day Raw Stochastic | 56.46% | 70.49% | 7.28% | ||
| 20-Day Relative Strength | 43.24 | 63.80 | 38.42 | ||
| Weighted Alpha | -50.43 | +4.26 | -38.14 | ||
| Today's Opinion | 88% Sell | 72% Buy | 88% Sell | ||
| Previous Opinion | 72% Sell | 72% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | -5.06% since 04/17/26 | -9.76% since 04/17/26 | ||
| Low | 8.46 on 09/08/21 | 1.4600 on 04/24/26 | 1.0833 on 04/24/26 | ||
| High | 10.26 on 09/02/21 | 1.6100 on 04/22/26 | 1.3000 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | +32.74% since 03/24/26 | -12.60% since 03/24/26 | ||
| Low | 6.31 on 08/20/21 | 1.0700 on 04/02/26 | 1.0833 on 04/24/26 | ||
| High | 10.26 on 09/02/21 | 1.6800 on 04/14/26 | 1.4500 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | +19.05% since 01/23/26 | -13.95% since 01/23/26 | ||
| Low | 6.31 on 08/20/21 | 0.9612 on 02/05/26 | 1.0701 on 03/03/26 | ||
| High | 15.72 on 06/16/21 | 1.6800 on 04/14/26 | 1.5100 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | +2.74% since 10/24/25 | -46.38% since 10/24/25 | ||
| Low | 6.31 on 08/20/21 | 0.9612 on 02/05/26 | 1.0100 on 12/31/25 | ||
| High | 22.01 on 03/18/21 | 1.6800 on 04/14/26 | 2.2900 on 11/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,610 | 32,010 | ||
| Shares Outstanding, K | 3,904 | 22,407 | 28,838 | ||
| Annual Sales | 0 | 0 | 54,220,000 | ||
| Annual Net Income | -37,300,000 | -58,200,000 | -57,890,000 | ||
| Last Quarter Sales | 0 | 0 | 5,280,000 | ||
| Last Quarter Net Income | -7,470,000 | -12,890,000 | -23,080,000 | ||
| 60-Month Beta | 1.66 | -0.86 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.58 on 03/09/26 | -0.88 on 11/14/25 | ||
| Latest Earnings Date | 11/11/21 | 05/08/26 | 09/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||